Institution statistics

BAYER PHARMA AG - Germany 

Ranking results:

Past rankings:
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 11
As coordinator: 0
As participant: 11
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 20.200.000 0 1
2016 0 21.085.937 0 2
2015 0 6.463.625 498.433 2
2014 0 4.000.000 400.000 1
2013 0 3.935.721 95.400 1
2011 0 12.766.589 638.857 3
2005 0 11.998.527 285.679 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV4
MEDIZINISCHE UNIVERSITAET WIEN4
GENOME RESEARCH3
NOVARTIS PHARMA3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
ABBVIE INC2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTELLAS PHARMA EUROPE BV2
ASTRAZENECA AB2
CANCER RESEARCH UK2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
F HOFFMANNLA ROCHE2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
HELSINGIN YLIOPISTO2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KUNGLIGA TEKNISKA HOEGSKOLAN2
NOVO NORDISK2
SANOFIAVENTIS DEUTSCHLAND2
TAKEDA DEVELOPMENT CENTRE EUROPE2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF NEWCASTLE UPON TYNE2
ABBVIE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACTELION PHARMACEUTICALS1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA1
AMGEN1
AMGEN LIMITED1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ARTTIC IN BRUSSELS SPRL1
ASSOCIATION POUR LA RECHERCHE DE THERAPEUTIQUES INNOVANTES EN CANCEROLOGIE1
AVENTIS PHARMA RECHERCHEDEVELOPPEMENT1
AXCENTUA PHARMACEUTICALS AB1
BARTS AND THE LONDON NHS TRUST1
BIOWISDOM LIMITED1
BOEHRINGER INGELHEIM INTERNATIONALGMBH1
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CAPSANT NEUROTECHNOLOGIES1
CELGENE MANAGEMENT SARL1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CEREBRICON1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CHU HOPITAUX DE BORDEAUX1
CIPHERGEN BIOSYSTEMS INC1
CONCENTRIS RESEARCH MANAGEMENT1
CSL BEHRING1
DANMARKS TEKNISKE UNIVERSITET1
DEPARTMENT OF OLD AGE PSYCHIATRY & PSYCHOTIC DISORDERS MEDICAL UNIVERSITY OF LODZ1
ELI LILLY AND COMPANY1
ERASMUS UNIVERSITEIT ROTTERDAM1
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN FEDERATION FOR PHARMACEUTICAL SCIENCES1
EUROPEAN FEDERATION OF BIOTECHNOLOGY1
EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN PATIENTS' FORUM1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
EXPERIMENTAL PHARMACOLOGY AND ONCOLOGY BERLINBUCH1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GENEDATA1
GILUPI1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GMV SOLUCIONES GLOBALES INTERNET SAU1
GPOH GEMEINNUTZIGE1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HACETTEPE UNIVERSITESI1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HORIZON DISCOVERY LIMITED1
HUNTER FLEMING LIMITED1
IKERLAN SCOOP1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT CURIE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
INSTITUT FUER PHOTONISCHE TECHNOLOGIEN EV1
INSTITUT GUSTAVE ROUSSY1
INSTITUTO DE MEDICINA MOLECULAR1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
Constancy:

Total number of partners:227

Partner loyalty:
Frequent Partner: (> 2 projects): 17
Rare Partner: 210

Frequent / Rare Partner Ratio: 0.08

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES5
RTD HORIZONTAL TOPICS2
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2015-10-01European Network linking informatics and genomics of helper T cells ENLIGHT-TENparticipant3.354.68511
2015-01-01Improving Design, Evaluation and Analysis of early drug development Studies IDEASparticipant3.108.9398
2014-01-01A CANcer Development mOnitor CanDoparticipant4.000.00010
2013-01-01RADical reduction of OXidative stress in cardiovascular diseases RADOXparticipant3.935.7219
2011-10-01Ion Transport Proteins in Control of Cancer Cell Behaviour IonTraCparticipant3.925.58010
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914
2005-10-01Innovative medicines for europe INNOMEDparticipant11.998.52742
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum